Population analysis of g.2488delG and three novel polymorphisms (g.4497G>A, g.4503G>A and g.2319G>A) in the plasminogen activator inhibitor 1 (PAI-1) gene.

Iwao M; Morisaki H; Matsunaga H; Morisaki T

首页> 外文期刊>Human mutation >Population analysis of g.2488delG and three novel polymorphisms (g.4497G>A, g.4503G>A and g.2319G>A) in the plasminogen activator inhibitor 1 (PAI-1) gene.

【24h】

Population analysis of g.2488delG and three novel polymorphisms (g.4497G>A, g.4503G>A and g.2319G>A) in the plasminogen activator inhibitor 1 (PAI-1) gene.

机译：纤溶酶原激活物抑制剂1（PAI-1）基因中g.2488delG和三个新的多态性（g.4497G> A，g.4503G> A和g.2319G> A）的群体分析。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Human mutation》 |2001年第4期|共1页
作者
Iwao M; Morisaki H; Matsunaga H; Morisaki T;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类基础医学;
关键词
Mutation; Missense; Plasminogen Activator Inhibitor 1; Polymorphism Genetics genetics; 突变; 误义; 纤溶酶原激活物抑制物1;

机译：Mutation;Missense;Plasminogen Activator Inhibitor 1;Polymorphism Genetics genetics;突变;误义;纤溶酶原激活物抑制物1;
入库时间 2022-08-18 21:24:52

相似文献

外文文献
中文文献
专利

1. Population analysis of g.2488delG and three novel polymorphisms (g.4497G>A, g.4503G>A and g.2319G>A) in the plasminogen activator inhibitor 1 (PAI-1) gene. [J] . Iwao M, Morisaki H, Matsunaga H, Human mutation . 2001,第4期

机译：纤溶酶原激活物抑制剂1（PAI-1）基因中g.2488delG和三个新的多态性（g.4497G> A，g.4503G> A和g.2319G> A）的群体分析。
2. Regular exercise, plasminogen activator inhibitor-1 (PAI-1) activity and the 4G/5G promoter polymorphism in the PAI-1 gene. [J] . Vaisanen SB, Humphries SE, Luong LA, Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 1999,第3期

机译：定期运动，PAI-1基因中的纤溶酶原激活物抑制剂1（PAI-1）活性和4G / 5G启动子多态性。
3. Increase in plasma plasminogen activators inhibitor type 1 concentration after fibrinolytic treatment in patients with acute myocardial infarction is associated with 4G/5G polymorphism of PAI-1 gene. [J] . Mlynarska A, Waszyrowski T, Kasprzak JD Journal of thrombosis and haemostasis: JTH . 2006,第6期

机译：急性心肌梗死患者经纤溶治疗后血浆纤溶酶原激活物抑制剂1型浓度的增加与PAI-1基因的4G / 5G多态性有关。
4. Plasminogen Activator Inhibitor I (PAI-I) -675 5G/4G Polymorphism in Patients with Coronary Artery Disease [C] . G. Apergis, M. Belia, A. Bratsas, International Congress on Thrombosis . 2004

机译：冠状动脉疾病患者的纤溶酶原激活剂抑制剂I（PAI-I）-675 5G / 4G多态性
5. Design, Synthesis, and Biological Evaluation of Non-Symmetric Small Molecules as Inhibitors of Plasminogen Activator Inhibitor (PAI-1). [D] . Anumala, Himabindu. 2014

机译：非对称小分子作为纤溶酶原激活物抑制剂（PAI-1）的抑制剂的设计，合成和生物学评估。
6. The Synergistic Effect of Plasminogen Activator Inhibitor-1 (PAI-1) Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population [O] . Han Sung Park, Jung-Hoon Sung, Chang Soo Ryu, 2020

机译：纤溶酶原激活剂抑制剂-1（PAI-1）多态性和代谢综合征对韩国人群冠状动脉疾病的协同作用
7. The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis [O] . Nikolopoulos G. K., Bagos P. G., Tsangaris I., 2014

机译：纤溶酶原激活物抑制剂1型（paI-1）水平，paI-1 4G / 5G多态性与心肌梗死之间的关系：孟德尔随机化荟萃分析

Population analysis of g.2488delG and three novel polymorphisms (g.4497G>A, g.4503G>A and g.2319G>A) in the plasminogen activator inhibitor 1 (PAI-1) gene.

著录项

相似文献

相关主题

期刊订阅